Tauroursodeoxycholic Acid Dihydrate CAS 14605-22-2 Assay 98.0~101.0%

Tauroursodeoxycholic Acid Dihydrate (TUDCA) (CAS: 14605-22-2) is an ambiphilic bile acid. is isolated from the bear bile of a natural bile acid, a chemical agent, in vivo and taurine in the presence of bile, is a hydrophilic cholic acid, as a cholesterol stone Dissolving agent.
Tauroursodeoxycholic Acid Dihydrate is the taurine conjugate form of Ursodeoxycholic Acid (UDCA). Humans are found to have trace amounts of TUDCA. Ongoing research is finding TUDCA has diminishing apoptotic effects, with potential application in heart disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and stroke. Recently, TUDCA has been found to have protective effects in the eye, especially concerning retinal degenerative disorders.
TUDCA was found in bear bile in 1902, which is the main active ingredient of bear bile and the main ingredient of synthetic bear bile. It is widely found in human and a variety of animal bile. It has a variety of physiological and pharmacological effects. The drug and its preparations have been listed abroad for 20 years of clinical experience, mainly used for sterol gallbladder stones, cholestatic liver disease (such as: primary biliary cirrhosis), bile reflux gastritis, autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), chronic hepatitis (hepatitis B, hepatitis C, etc.), alcoholic fatty liver, non-alcoholic fatty liver, drug-induced liver damage, prevention and treatment of complications before and after liver transplantation.
Tauroursodeoxycholic Acid Dihydrate has antispasmodic, anticonvulsant, anti-inflammatory and gallstone-soluble effects. Biochemical research; Lipase accelerator; Anion remover, used for protein dissolution; Preparation of bacterial culture medium (intestinal bacteria culture and separation) Used for content determination/identification/pharmacological experiments, etc.